611 related articles for article (PubMed ID: 26471017)
1. Lupus nephritis: an update.
Imran TF; Yick F; Verma S; Estiverne C; Ogbonnaya-Odor C; Thiruvarudsothy S; Reddi AS; Kothari N
Clin Exp Nephrol; 2016 Feb; 20(1):1-13. PubMed ID: 26471017
[TBL] [Abstract][Full Text] [Related]
2. [Lupusnephritis].
Haubitz M
Z Rheumatol; 2012 Dec; 71(10):875-84; quiz 885-6. PubMed ID: 23202997
[TBL] [Abstract][Full Text] [Related]
3. [Clinical guideline for the treatment of lupus nephritis and single-centre results of mycofenolate mofetil among patients with lupus nephritis in the National Institute of Rheumatology and Physiotherapy, Budapest].
Szabó MZ; Kiss E
Orv Hetil; 2016 Aug; 157(35):1385-93. PubMed ID: 27569461
[TBL] [Abstract][Full Text] [Related]
4. The safety of pharmacological treatment options for lupus nephritis.
Velo-García A; Ntatsaki E; Isenberg D
Expert Opin Drug Saf; 2016 Aug; 15(8):1041-54. PubMed ID: 27159360
[TBL] [Abstract][Full Text] [Related]
5. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
7. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone.
Cortés-Hernández J; Ordi-Ros J; Labrador M; Segarra A; Tovar JL; Balada E; Vilardell-Tarres M
Lupus; 2003; 12(4):287-96. PubMed ID: 12729052
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a mycophenolate mofetil-refractory proliferative lupus nephritis with Belimumab in a 19-year-old woman.
Fließer EE; Korsten P; Koziolek MJ; Niewold TB; Patschan D; Müller GA; Patschan SA
Lupus; 2013 Dec; 22(14):1523-5. PubMed ID: 24014569
[TBL] [Abstract][Full Text] [Related]
9. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
Staveri C; Karokis D; Liossis SC
Semin Arthritis Rheum; 2017 Jun; 46(6):788-790. PubMed ID: 27793432
[TBL] [Abstract][Full Text] [Related]
10. Update on the treatment of lupus nephritis.
Waldman M; Appel GB
Kidney Int; 2006 Oct; 70(8):1403-12. PubMed ID: 16929249
[TBL] [Abstract][Full Text] [Related]
11. Systemic Lupus Erythematosus: A Review.
Siegel CH; Sammaritano LR
JAMA; 2024 May; 331(17):1480-1491. PubMed ID: 38587826
[TBL] [Abstract][Full Text] [Related]
12. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.
Tanaka H; Joh K; Imaizumi T
Clin Exp Nephrol; 2017 Oct; 21(5):755-763. PubMed ID: 28258497
[TBL] [Abstract][Full Text] [Related]
14. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
15. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
16. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
17. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
18. Update on the treatment of lupus nephritis.
Hogan J; Appel GB
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):224-30. PubMed ID: 23328501
[TBL] [Abstract][Full Text] [Related]
19. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
Ruiz-Irastorza G; Danza A; Khamashta M
Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
